BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38568812)

  • 21. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
    Vincent DF; Yan KP; Treilleux I; Gay F; Arfi V; Kaniewski B; Marie JC; Lepinasse F; Martel S; Goddard-Leon S; Iovanna JL; Dubus P; Garcia S; Puisieux A; Rimokh R; Bardeesy N; Scoazec JY; Losson R; Bartholin L
    PLoS Genet; 2009 Jul; 5(7):e1000575. PubMed ID: 19629168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics.
    Singh SK; Ellenrieder V
    Gut; 2013 Sep; 62(9):1364-72. PubMed ID: 23408353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
    Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
    J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
    Parameswaran N; Bartel CA; Hernandez-Sanchez W; Miskimen KL; Smigiel JM; Khalil AM; Jackson MW
    Sci Rep; 2019 Sep; 9(1):13396. PubMed ID: 31527715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.
    Ray KC; Moss ME; Franklin JL; Weaver CJ; Higginbotham J; Song Y; Revetta FL; Blaine SA; Bridges LR; Guess KE; Coffey RJ; Crawford HC; Washington MK; Means AL
    Oncogene; 2014 Feb; 33(7):823-31. PubMed ID: 23376846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
    Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
    Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.
    Doffo J; Bamopoulos SA; Köse H; Orben F; Zang C; Pons M; den Dekker AT; Brouwer RWW; Baluapuri A; Habringer S; Reichert M; Illendula A; Krämer OH; Schick M; Wolf E; van IJcken WFJ; Esposito I; Keller U; Schneider G; Wirth M
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy.
    Kong B; Bruns P; Behler NA; Chang L; Schlitter AM; Cao J; Gewies A; Ruland J; Fritzsche S; Valkovskaya N; Jian Z; Regel I; Raulefs S; Irmler M; Beckers J; Friess H; Erkan M; Mueller NS; Roth S; Hackert T; Esposito I; Theis FJ; Kleeff J; Michalski CW
    Gut; 2018 Jan; 67(1):146-156. PubMed ID: 27646934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis.
    Carrer A; Trefely S; Zhao S; Campbell SL; Norgard RJ; Schultz KC; Sidoli S; Parris JLD; Affronti HC; Sivanand S; Egolf S; Sela Y; Trizzino M; Gardini A; Garcia BA; Snyder NW; Stanger BZ; Wellen KE
    Cancer Discov; 2019 Mar; 9(3):416-435. PubMed ID: 30626590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.
    Rai TS; Cole JJ; Nelson DM; Dikovskaya D; Faller WJ; Vizioli MG; Hewitt RN; Anannya O; McBryan T; Manoharan I; van Tuyn J; Morrice N; Pchelintsev NA; Ivanov A; Brock C; Drotar ME; Nixon C; Clark W; Sansom OJ; Anderson KI; King A; Blyth K; Adams PD
    Genes Dev; 2014 Dec; 28(24):2712-25. PubMed ID: 25512559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
    Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer.
    Caldwell ME; DeNicola GM; Martins CP; Jacobetz MA; Maitra A; Hruban RH; Tuveson DA
    Oncogene; 2012 Mar; 31(12):1599-608. PubMed ID: 21860420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
    Benitz S; Regel I; Reinhard T; Popp A; Schäffer I; Raulefs S; Kong B; Esposito I; Michalski CW; Kleeff J
    Oncotarget; 2016 Mar; 7(10):11424-33. PubMed ID: 26716510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.
    Tsuda M; Fukuda A; Roy N; Hiramatsu Y; Leonhardt L; Kakiuchi N; Hoyer K; Ogawa S; Goto N; Ikuta K; Kimura Y; Matsumoto Y; Takada Y; Yoshioka T; Maruno T; Yamaga Y; Kim GE; Akiyama H; Ogawa S; Wright CV; Saur D; Takaori K; Uemoto S; Hebrok M; Chiba T; Seno H
    J Clin Invest; 2018 Aug; 128(8):3475-3489. PubMed ID: 30010625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
    Diersch S; Wirth M; Schneeweis C; Jörs S; Geisler F; Siveke JT; Rad R; Schmid RM; Saur D; Rustgi AK; Reichert M; Schneider G
    Oncogene; 2016 Jul; 35(29):3880-6. PubMed ID: 26592448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.